#	Pagina
attuale pagina	/open-h2020/projects/196171/index.html

Opendata, web and dolomites

CELLETEST

Liquid Biopsy blood test in lung cancer diagnosis and monitoring: a next generation noninvasive tumor tracker device

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

CELLETEST project word cloud

Explore the words cloud of the CELLETEST project. It provides you a very rough idea of what is the project "CELLETEST" about.

bloodstream blood examined proprietary celletest characterization prescribing implies extraction ultimate prognosis cells alternative circulating gold therapy interventional lung utility molecular metastatic surgical biopsied ctcs diagnosis cancers promise disruptive tumor device validate patients biomarkers optimal clinical morphological biopsy anticancer monitoring holds cancer generation liquid biochemical procedure site isolation typology obtain standard therapies evolution invasive medical clinically tissue

Project "CELLETEST" data sheet

The following table provides information about the project.

Coordinator	STEM SEL SRL Organization address address: VIALE GIUSEPPE FANIN 48 city: BOLOGNA postcode: 40127 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Italy [IT]
Project website	http://barbara.roda
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3.1.3. (Treating and managing disease)
Code Call	H2020-SMEINST-1-2014
Funding Scheme	SME-1
Starting year	2015
Duration (year-month-day)	from 2015-02-02 to 2015-06-01

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	STEM SEL SRL STEM SEL SRL Organization address address: VIALE GIUSEPPE FANIN 48 city: BOLOGNA postcode: 40127 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IT (BOLOGNA)	coordinator	50˙000.00

Map

Project objective

The ultimate objective of the Celletest project is to develop a next generation medical device for non-invasive diagnosis and prognosis of metastatic lung cancer, so we can validate the . To achieve this ambitious objective, we will exploit the potential of our proprietary technology for isolation of circulating tumor cells from the bloodstream, so we can validate the clinical utility of CTCs, which have been already identified as biomarkers for the liquid-biopsy of metastatic lung cancers. What is a Liquid Biopsy? Liquid biopsy is an emerging and disruptive technology in cancer diagnosis, prognosis and monitoring of evolution of cancer patients under anticancer therapies. This novel technology can be understood as the next generation non-invasive alternative to the current gold standard in cancer diagnosis, tissue biopsy. Tissue biopsy implies an interventional/surgical procedure to sample cells or tissue at the tumor site. The biopsied tissue is examined and analyzed (molecular characterization for the determination of the molecular biomarkers of cancer cells) in order to characterize the cancer cells according to their morphological and biochemical properties. This allows determining the tumor typology and prescribing the most optimal anticancer therapy. Liquid biopsy holds promise as a non-invasive method capable to obtain the same clinically relevant information with just a simple blood extraction.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CELLETEST" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CELLETEST" are provided by the European Opendata Portal: CORDIS opendata.